GENE EDITING 101
All Companies
🇺🇸

Wave Life Sciences

Public

Programmable RNA editing

Wave Life Sciences is pioneering endogenous RNA editing — using the body's own ADAR enzymes to make reversible changes to RNA. Their approach requires no permanent DNA changes and is fully reversible.

Founded2012
HQCambridge, MA
CEOPaul Bolno
TickerNASDAQ:WVE
Total Funding$1.0B

Pipeline

Drug / ProgramIndicationPhaseTechnology
WVE-006Alpha-1 Antitrypsin DeficiencyPhase 1RNA Editing
WVE-007NeurologicalPreclinicalRNA Editing

Key People

Paul BolnoCEO

Related Articles

Life Biosciences: The Startup Trying to Reverse Aging in Humans
Longevity Science
Deep Dive

Life Biosciences: The Startup Trying to Reverse Aging in Humans

Life Biosciences launched the first-ever human trial of epigenetic reprogramming in January 2026 — an AAV gene therapy that uses three Yamanaka factors to reverse aging in the eye. Here's the full story of the company, its science, and what it means for the future of longevity medicine.

Mar 28, 202614 min read
Every Longevity Biotech Company You Should Know in 2026
Longevity Science
Market Analysis

Every Longevity Biotech Company You Should Know in 2026

From billion-dollar reprogramming ventures to canine longevity drugs, here are the biotech companies leading the charge against aging in 2026.

Mar 25, 20268 min read